FAT1 knockdown in glioblastoma cell lines resulted in promotion of cell cycle progression and cellular growth and in a breast cancer xenograft model FAT1 knockdown resulted in the progression of ductal carcinoma in situ to invasive breast cancer [75, 76]. This evidence concerns the gene FAT1 and invasive breast carcinoma.